Analyst Consensus ?
ConsensusBuy84 ratings
Bullish5565.5%
Neutral2529.7%
Bearish44.8%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
Oracle Corporation complete analyst coverage
Oracle Corporation (ORCL) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$155.62Current
$80Low
$237.68Average
$400High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 11, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Sep 9, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Sep 9, 2026 |
| Guggenheim | Buy | Buy | Maintain | Sep 8, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Sep 4, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Sep 4, 2026 |
| Jefferies | Buy | Buy | Maintain | Sep 2, 2026 |
| TD Cowen | Buy | Buy | Maintain | Sep 1, 2026 |
| UBS | Buy | Buy | Maintain | Aug 6, 2026 |
| Wedbush | Outperform | Outperform | Maintain | Jun 11, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jun 11, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jun 11, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jun 11, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jun 11, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jun 11, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jun 11, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jun 11, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jun 9, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jun 8, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jun 8, 2026 |
| BTIG | Buy | Buy | Maintain | Jun 5, 2026 |
| Citigroup | Buy | Buy | Maintain | Jun 4, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Mar 16, 2026 |
| Stifel | Buy | Buy | Maintain | Mar 11, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | Mar 11, 2026 |
| Baird | Outperform | Outperform | Maintain | Mar 10, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Mar 9, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Dec 12, 2025 |
| Keybanc | Overweight | Overweight | Maintain | Dec 11, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 17, 2025 |
| Berenberg | Hold | Hold | Maintain | Sep 15, 2025 |
| Wolfe Research | Outperform | Outperform | Maintain | Sep 10, 2025 |
| Melius Research | Buy | Buy | Maintain | Sep 10, 2025 |
| WestPark Capital | Buy | Buy | Maintain | Jun 12, 2025 |
| Citizens Capital Markets | Market Outperform | Market Outperform | Maintain | Mar 11, 2025 |
| Argus Research | Buy | Buy | Maintain | Jun 18, 2024 |
| HSBC | Buy | Buy | Maintain | Mar 13, 2024 |
| William Blair | Outperform | Market Perform | Upgrade | Mar 12, 2024 |
| Erste Group | Hold | Buy | Downgrade | Dec 22, 2023 |
| Edward Jones | Buy | Hold | Upgrade | Nov 13, 2023 |
| DZ Bank | Buy | Hold | Upgrade | Sep 14, 2023 |
| Monness, Crespi, Hardt | Neutral | Buy | Downgrade | Sep 12, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Mar 15, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Dec 13, 2022 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Jun 29, 2022 |
| Daiwa Capital | Neutral | Neutral | Maintain | Jun 27, 2022 |
| Societe Generale | Hold | Hold | Maintain | Dec 10, 2021 |
| Wells Fargo | Overweight | Overweight | Maintain | Mar 11, 2021 |
| Cleveland Research | Neutral | Buy | Downgrade | Dec 8, 2020 |
| Raymond James | Outperform | Outperform | Maintain | Mar 13, 2020 |
| Nomura | Reduce | Reduce | Maintain | Dec 16, 2019 |
| Macquarie | Neutral | Outperform | Downgrade | Jun 18, 2019 |
| Atlantic Equities | Underweight | Underweight | Maintain | Jan 9, 2019 |
| Standpoint Research | Buy | Hold | Upgrade | Dec 26, 2018 |
| Needham | Hold | Hold | Maintain | Oct 23, 2018 |
| Stifel Nicolaus | Hold | Hold | Maintain | Sep 18, 2018 |
| Bank of America | Neutral | Neutral | Maintain | Sep 18, 2018 |
| Rosenblatt | Neutral | Buy | Downgrade | Jun 20, 2018 |
| Monness Crespi Hardt | Neutral | Neutral | Maintain | Apr 11, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Oct 4, 2017 |
| Moffett Nathanson | Buy | Buy | Maintain | Sep 6, 2017 |
| Argus | Buy | Hold | Upgrade | Jun 23, 2017 |
| Benchmark | Buy | Buy | Maintain | Apr 27, 2017 |
| OTR Global | Mixed | Positive | Downgrade | Sep 8, 2016 |
| BTIG Research | Buy | Buy | Maintain | Jul 14, 2016 |
| Wunderlich Securities | Hold | Buy | Downgrade | Jun 17, 2016 |
| Wunderlich | Hold | Buy | Downgrade | Jun 17, 2016 |
| Pacific Crest | Sector Weight | Maintain | Jun 17, 2016 | |
| Canaccord Genuity | Buy | Buy | Maintain | Mar 16, 2016 |
| FBR Capital | Market Perform | Outperform | Downgrade | Nov 5, 2015 |
| SunTrust Robinson Humphrey | Buy | Neutral | Upgrade | Sep 16, 2015 |
| Tigress Financial | Neutral | Buy | Downgrade | Oct 22, 2014 |
| D.A. Davidson | Buy | Neutral | Upgrade | Oct 6, 2014 |
| MKM Partners | Neutral | Neutral | Maintain | Sep 10, 2014 |
| Maxim Group | Buy | Buy | Maintain | Jun 4, 2014 |
| JG Capital | Underweight | Neutral | Downgrade | Apr 15, 2014 |
| Argus Capital | Hold | Buy | Downgrade | Mar 20, 2014 |
| Susquehanna | Positive | Positive | Maintain | Mar 3, 2014 |
| Sterne Agee | Neutral | Neutral | Maintain | Feb 4, 2014 |
| LBBW Research | Buy | Hold | Upgrade | Dec 20, 2013 |
| Evercore Partners | Equal Weight | Overweight | Downgrade | Mar 21, 2013 |
| CLSA | Underperform | Outperform | Downgrade | Mar 21, 2013 |
| Davenport | Buy | Neutral | Upgrade | Jan 11, 2013 |
| Janney Capital | Buy | Buy | Maintain | Dec 14, 2012 |
| Longbow Research | Buy | Buy | Maintain | Aug 20, 2012 |
| Morgan Keegan | Outperform | Outperform | Maintain | Mar 21, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $155.62. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Sanjit Singh | $210 | $154.04 | +34.9% | Sep 4, 2026 |
| Jefferies | Brent Thill | $290 | $141.26 | +86.4% | Sep 2, 2026 |
| Bernstein | Mark Moerdler | $95 | $148.91 | -39.0% | Aug 12, 2026 |
| UBS | Karl Keirstead | $245 | $144.36 | +57.4% | Aug 6, 2026 |
| CLSA | Bhavtosh Vajpayee | $145 | $126.48 | -6.8% | Jul 20, 2026 |
| D.A. Davidson | Analyst unavailable | $225 | $180.22 | +44.6% | Jun 11, 2026 |
| Wedbush | Analyst unavailable | $240 | $201.26 | +54.2% | Jun 11, 2026 |
| BMO Capital | Keith Bachman | $220 | $201.26 | +41.4% | Jun 11, 2026 |
| Bernstein | Mark Moerdler | $325 | $201.26 | +108.8% | Jun 11, 2026 |
| Piper Sandler | Analyst unavailable | $225 | $201.26 | +44.6% | Jun 11, 2026 |
| Scotiabank | Pat Colville | $241 | $201.26 | +54.9% | Jun 11, 2026 |
| Wolfe Research | Alex Zukin | $225 | $201.26 | +44.6% | Jun 11, 2026 |
| Barclays | Raimo Lenschow | $250 | $201.26 | +60.6% | Jun 11, 2026 |
| MoffettNathanson | Analyst unavailable | $325 | $201.26 | +108.8% | Jun 11, 2026 |
| Oppenheimer | Brian Schwartz | $275 | $213.41 | +76.7% | Jun 8, 2026 |
| Evercore ISI | Kirk Materne | $245 | $213.41 | +57.4% | Jun 8, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $284 | $220.15 | +82.5% | Jun 5, 2026 |
| RBC Capital | Analyst unavailable | $190 | $236.34 | +22.1% | Jun 4, 2026 |
| Mizuho Securities | Siti Panigrahi | $320 | $244.54 | +105.6% | Jun 3, 2026 |
| UBS | Karl Keirstead | $285 | $239.41 | +83.1% | Jun 2, 2026 |
| Scotiabank | Pat Colville | $290 | $248.07 | +86.4% | Jun 2, 2026 |
| Wedbush | Analyst unavailable | $275 | $187.74 | +76.7% | May 13, 2026 |
| Oppenheimer | Brian Schwartz | $235 | $193.83 | +51.0% | May 12, 2026 |
| Arete Research | Analyst unavailable | $255 | $193.99 | +63.9% | May 7, 2026 |
| Wedbush | Analyst unavailable | $225 | $176.28 | +44.6% | Apr 24, 2026 |
| Morgan Stanley | Keith Weiss | $207 | $175.66 | +33.0% | Apr 23, 2026 |
| Deutsche Bank | Brad Zelnick | $300 | $162.32 | +92.8% | Mar 11, 2026 |
| RBC Capital | Rishi Jaluria | $160 | $163.12 | +2.8% | Mar 11, 2026 |
| Stifel Nicolaus | Brad Reback | $220 | $163.12 | +41.4% | Mar 11, 2026 |
| Scotiabank | Analyst unavailable | $215 | $151.56 | +38.2% | Mar 9, 2026 |
| Cantor Fitzgerald | Thomas Blakey | $229 | $151.56 | +47.2% | Mar 9, 2026 |
| Barclays | Raimo Lenschow | $230 | $151.56 | +47.8% | Mar 9, 2026 |
| Jefferies | Brent Thill | $320 | $154.67 | +105.6% | Mar 5, 2026 |
| Melius Research | Ben Reitzes | $160 | $156.56 | +2.8% | Feb 9, 2026 |
| Bernstein | Analyst unavailable | $313 | $142.78 | +101.1% | Feb 9, 2026 |
| BMO Capital | Analyst unavailable | $205 | $147.05 | +31.7% | Feb 4, 2026 |
| Scotiabank | Analyst unavailable | $220 | $155.02 | +41.4% | Feb 3, 2026 |
| Piper Sandler | Analyst unavailable | $240 | $160.13 | +54.2% | Feb 2, 2026 |
| Morgan Stanley | Analyst unavailable | $213 | $178.16 | +36.9% | Jan 23, 2026 |
| Goldman Sachs | Analyst unavailable | $240 | $198.52 | +54.2% | Jan 11, 2026 |
| UBS | Analyst unavailable | $280 | $196.11 | +79.9% | Jan 5, 2026 |
| RBC Capital | Rishi Jaluria | $195 | $195.71 | +25.3% | Jan 5, 2026 |
| Mizuho Securities | Siti Panigrahi | $400 | $189.59 | +157.0% | Dec 15, 2025 |
| Goldman Sachs | Kash Rangan | $220 | $198.64 | +41.4% | Dec 12, 2025 |
| UBS | Analyst unavailable | $325 | $192.66 | +108.8% | Dec 11, 2025 |
| KeyBanc | Jackson Ader | $300 | $192.13 | +92.8% | Dec 11, 2025 |
| D.A. Davidson | Analyst unavailable | $180 | $189.94 | +15.7% | Dec 11, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $320 | $189.62 | +105.6% | Dec 11, 2025 |
| RBC Capital | Analyst unavailable | $250 | $223.3 | +60.6% | Dec 11, 2025 |
| Stifel Nicolaus | Brad Reback | $275 | $223.3 | +76.7% | Dec 11, 2025 |
| Barclays | Raimo Lenschow | $310 | $223.3 | +99.2% | Dec 11, 2025 |
| BMO Capital | Analyst unavailable | $270 | $223.3 | +73.5% | Dec 11, 2025 |
| Scotiabank | Pat Colville | $260 | $193.21 | +67.1% | Dec 11, 2025 |
| Bernstein | Analyst unavailable | $339 | $223.3 | +117.8% | Dec 11, 2025 |
| Piper Sandler | Analyst unavailable | $290 | $223.3 | +86.4% | Dec 11, 2025 |
| Barclays | Analyst unavailable | $330 | $217.58 | +112.1% | Dec 8, 2025 |
| RBC Capital | Rishi Jaluria | $310 | $217.17 | +99.2% | Dec 5, 2025 |
| Wells Fargo | Analyst unavailable | $280 | $201.1 | +79.9% | Dec 3, 2025 |
| HSBC | Stephen Bersey | $382 | $205.21 | +145.5% | Nov 26, 2025 |
| Deutsche Bank | Brad Zelnick | $375 | $205.26 | +141.0% | Nov 26, 2025 |
| D.A. Davidson | Gil Luria | $200 | $199.88 | +28.5% | Nov 25, 2025 |
| Robert W. Baird | Analyst unavailable | $315 | $220.49 | +102.4% | Nov 18, 2025 |
| Goldman Sachs | Analyst unavailable | $320 | $288.95 | +105.6% | Oct 20, 2025 |
| Scotiabank | Patrick Colville | $360 | $291.23 | +131.3% | Oct 17, 2025 |
| Evercore ISI | Analyst unavailable | $385 | $313 | +147.4% | Oct 17, 2025 |
| Stephens | Brett Huff | $331 | $313 | +112.7% | Oct 17, 2025 |
| Piper Sandler | Brent Bracelin | $380 | $313 | +144.2% | Oct 17, 2025 |
| Guggenheim | John DiFucci | $400 | $313 | +157.0% | Oct 17, 2025 |
| UBS | Karl Keirstead | $380 | $313 | +144.2% | Oct 17, 2025 |
| Barclays | Analyst unavailable | $400 | $313 | +157.0% | Oct 17, 2025 |
| Jefferies | Analyst unavailable | $400 | $313 | +157.0% | Oct 17, 2025 |
| BMO Capital | Keith Bachman | $355 | $292.96 | +128.1% | Oct 13, 2025 |
| Evercore ISI | Kirk Materne | $350 | $296.96 | +124.9% | Oct 10, 2025 |
| Robert W. Baird | Analyst unavailable | $365 | $288.63 | +134.5% | Oct 8, 2025 |
| UBS | Analyst unavailable | $364 | $291.41 | +133.9% | Sep 26, 2025 |
| Redburn Partners | Alex Haissl | $175 | $295.08 | +12.5% | Sep 25, 2025 |
| BNP Paribas | Analyst unavailable | $377 | $328.33 | +142.3% | Sep 10, 2025 |
| Scotiabank | Patrick Colville | $350 | $328.33 | +124.9% | Sep 10, 2025 |
| UBS | Analyst unavailable | $300 | $328.33 | +92.8% | Sep 10, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $400 | $328.33 | +157.0% | Sep 10, 2025 |
| Cowen & Co. | Analyst unavailable | $375 | $328.33 | +141.0% | Sep 10, 2025 |
| UBS | Karl Keirstead | $360 | $328.33 | +131.3% | Sep 10, 2025 |
| Mizuho Securities | Analyst unavailable | $350 | $328.33 | +124.9% | Sep 10, 2025 |
| BMO Capital | Analyst unavailable | $345 | $328.33 | +121.7% | Sep 10, 2025 |
| Guggenheim | John DiFucci | $375 | $337.28 | +141.0% | Sep 10, 2025 |
| Evercore ISI | Analyst unavailable | $340 | $328.33 | +118.5% | Sep 10, 2025 |
| Jefferies | Analyst unavailable | $360 | $328.33 | +131.3% | Sep 10, 2025 |
| Stifel Nicolaus | Analyst unavailable | $350 | $328.33 | +124.9% | Sep 10, 2025 |
| Piper Sandler | Analyst unavailable | $330 | $328.33 | +112.1% | Sep 10, 2025 |
| Melius Research | Analyst unavailable | $370 | $328.33 | +137.8% | Sep 10, 2025 |
| JMP Securities | Patrick Walravens | $342 | $337.12 | +119.8% | Sep 10, 2025 |
| BMO Capital | Keith Bachman | $275 | $241.51 | +76.7% | Sep 9, 2025 |
| Barclays | Raimo Lenschow | $281 | $238.48 | +80.6% | Sep 8, 2025 |
| UBS | Karl Keirstead | $250 | $210.72 | +60.6% | Jun 25, 2025 |
| Guggenheim | John DiFucci | $250 | $210.87 | +60.6% | Jun 18, 2025 |
| JMP Securities | Patrick Walravens | $240 | $199.86 | +54.2% | Jun 12, 2025 |
| Loop Capital Markets | Mark Murphy | $135 | $177.48 | -13.3% | Jun 10, 2025 |
| Morgan Stanley | Keith Weiss | $175 | $177.15 | +12.5% | Jun 9, 2025 |
| Morgan Stanley | Keith Weiss | $160 | $129.76 | +2.8% | Apr 16, 2025 |
| D.A. Davidson | Gil Luria | $140 | $134.64 | -10.0% | Apr 14, 2025 |
| Stephens | Analyst unavailable | $167 | $149.45 | +7.3% | Mar 18, 2025 |
| RBC Capital | Rishi Jaluria | $145 | $144.18 | -6.8% | Mar 11, 2025 |
| Piper Sandler | Analyst unavailable | $190 | $144.18 | +22.1% | Mar 11, 2025 |
| Barclays | Raimo Lenschow | $202 | $144.18 | +29.8% | Mar 11, 2025 |
| Monness | Brian White | $130 | $167.2 | -16.5% | Dec 20, 2024 |
| Argus Research | Joseph Bonner | $200 | $178.58 | +28.5% | Dec 11, 2024 |
| UBS | Karl Keirstead | $210 | $177.74 | +34.9% | Dec 10, 2024 |
| Guggenheim | John DiFucci | $220 | $187.52 | +41.4% | Dec 5, 2024 |
| RBC Capital | Rishi Jaluria | $165 | $175.31 | +6.0% | Oct 23, 2024 |
| HSBC | Stephen Bersey | $210 | $170.11 | +34.9% | Sep 16, 2024 |
| Jefferies | Brent Thill | $190 | $162.03 | +22.1% | Sep 15, 2024 |
| Piper Sandler | Brent Bracelin | $185 | $164.56 | +18.9% | Sep 13, 2024 |
| Citigroup | Tyler Radke | $157 | $161.38 | +0.9% | Sep 13, 2024 |
| Deutsche Bank | Brad Zelnick | $200 | $161.38 | +28.5% | Sep 13, 2024 |
| Evercore ISI | Kirk Materne | $190 | $161.38 | +22.1% | Sep 13, 2024 |
| KeyBanc | Jackson Ader | $190 | $161.38 | +22.1% | Sep 13, 2024 |
| UBS | Karl Keirstead | $200 | $161.38 | +28.5% | Sep 13, 2024 |
| JMP Securities | Patrick Walravens | $175 | $156.59 | +12.5% | Sep 10, 2024 |
| JMP Securities | Silvan Tuerkcan | $80 | $156.38 | -48.6% | Sep 10, 2024 |
| BMO Capital | Keith Bachman | $173 | $156.8 | +11.2% | Sep 10, 2024 |
| Piper Sandler | Brent Bracelin | $175 | $156.82 | +12.5% | Sep 10, 2024 |
| Stifel Nicolaus | Brad Reback | $155 | $156.48 | -0.4% | Sep 10, 2024 |
| Melius Research | Ben Reitzes | $155 | $156.64 | -0.4% | Sep 10, 2024 |
| Mizuho Securities | Siti Panigrahi | $185 | $155.89 | +18.9% | Sep 10, 2024 |
| KeyBanc | Jackson Ader | $175 | $156.52 | +12.5% | Sep 10, 2024 |
| BMO Capital | Keith Bachman | $160 | $142.34 | +2.8% | Sep 9, 2024 |
| Bernstein | Mark Moerdler | $171 | $141.55 | +9.9% | Sep 3, 2024 |
| Jefferies | Brent Thill | $150 | $140.68 | -3.6% | Jul 9, 2024 |
| Argus Research | Joseph Bonner | $159 | $141.31 | +2.2% | Jun 18, 2024 |
| Mizuho Securities | Siti Panigrahi | $170 | $139.33 | +9.2% | Jun 17, 2024 |
| Piper Sandler | Brent Bracelin | $150 | $123.88 | -3.6% | Jun 12, 2024 |
| Morgan Stanley | Keith Weiss | $125 | $123.88 | -19.7% | Jun 12, 2024 |
| Barclays | Raimo Lenschow | $160 | $139.64 | +2.8% | Jun 12, 2024 |
| Stifel Nicolaus | Brad Reback | $135 | $123.88 | -13.3% | Jun 12, 2024 |
| CFRA | Angelo Zino | $150 | $123.88 | -3.6% | Jun 12, 2024 |
| Deutsche Bank | Brad Zelnick | $150 | $123.88 | -3.6% | Jun 12, 2024 |
| Evercore ISI | Kirk Materne | $160 | $123.88 | +2.8% | Jun 12, 2024 |
| D.A. Davidson | Gil Luria | $105 | $123.88 | -32.5% | Jun 12, 2024 |
| KeyBanc | Jackson Ader | $165 | $139.15 | +6.0% | Jun 12, 2024 |
| Morgan Stanley | Keith Weiss | $155 | $124.5 | -0.4% | Jun 10, 2024 |
| Barclays | Raimo Lenschow | $147 | $124.5 | -5.5% | Jun 10, 2024 |
| BMO Capital | Keith Bachman | $142 | $123.68 | -8.8% | Jun 6, 2024 |
| UBS | Karl Keirstead | $150 | $114.53 | -3.6% | Apr 22, 2024 |
| KeyBanc | Jackson Ader | $150 | $129.24 | -3.6% | Mar 20, 2024 |
| Argus Research | Joseph Bonner | $145 | $125.53 | -6.8% | Mar 14, 2024 |
| HSBC | Stephen Bersey | $152 | $125.52 | -2.3% | Mar 13, 2024 |
| Piper Sandler | Brent Bracelin | $140 | $127.54 | -10.0% | Mar 12, 2024 |
| CFRA | Angelo Zino | $142 | $127.54 | -8.8% | Mar 12, 2024 |
| Stifel Nicolaus | Brad Reback | $120 | $127.54 | -22.9% | Mar 12, 2024 |
| Mizuho Securities | Siti Panigrahi | $160 | $127.54 | +2.8% | Mar 12, 2024 |
| Berenberg Bank | Nay Soe Naing | $110 | $112.87 | -29.3% | Dec 8, 2023 |
| Mizuho Securities | Siti Panigrahi | $150 | $112.3 | -3.6% | Dec 7, 2023 |
| Guggenheim | John DiFucci | $150 | $109.03 | -3.6% | Sep 22, 2023 |
| Jefferies | Brent Thill | $145 | $126.32 | -6.8% | Sep 11, 2023 |
| UBS | Karl Keirstead | $140 | $116.84 | -10.0% | Aug 28, 2023 |
| Morgan Stanley | Keith Weiss | $105 | $118.03 | -32.5% | Jun 13, 2023 |
| Goldman Sachs | Kash Rangan | $120 | $116.43 | -22.9% | Jun 13, 2023 |
| Wolfe Research | Alex Zukin | $130 | $109.85 | -16.5% | Jun 12, 2023 |
| J.P. Morgan | Mark Murphy | $93 | $107.48 | -40.2% | Jun 9, 2023 |
| Mizuho Securities | Siti Panigrahi | $116 | $83.87 | -25.5% | Mar 10, 2023 |
| Piper Sandler | Analyst unavailable | $104 | $85.66 | -33.2% | Jan 9, 2023 |
| Jefferies | Analyst unavailable | $105 | $84.62 | -32.5% | Jan 5, 2023 |
| Guggenheim | John DiFucci | $115 | $82.26 | -26.1% | Dec 13, 2022 |
| Cowen & Co. | Analyst unavailable | $96 | $83.01 | -38.3% | Dec 13, 2022 |
| Piper Sandler | Analyst unavailable | $85 | $81.28 | -45.4% | Dec 13, 2022 |
| Barclays | Analyst unavailable | $81 | $83.35 | -48.0% | Dec 5, 2022 |
| Morgan Stanley | Keith Weiss | $90 | $77.2 | -42.2% | Sep 13, 2022 |
| Jefferies | Brent Thill | $85 | $77.08 | -45.4% | Sep 13, 2022 |
| Piper Sandler | Brent Bracelin | $70 | $77.08 | -55.0% | Sep 13, 2022 |
| Evercore ISI | Kirk Materne | $87 | $76.04 | -44.1% | Sep 13, 2022 |
| BMO Capital | Keith Bachman | $90 | $76.04 | -42.2% | Sep 13, 2022 |
| Credit Suisse | Phil Winslow's | $115 | $73.83 | -26.1% | Jul 21, 2022 |
| BNP Paribas | Stefan Slowinski | $90 | $70.87 | -42.2% | Jul 4, 2022 |
| Stifel Nicolaus | Brad Reback | $72 | $64.05 | -53.7% | Jun 14, 2022 |
| Jefferies | Brent Thill | $80 | $70.72 | -48.6% | Jun 14, 2022 |
| Citigroup | Tyler Radke | $75 | $64.05 | -51.8% | Jun 13, 2022 |
| Evercore ISI | Kirk Materne | $88 | $67.14 | -43.5% | Jun 10, 2022 |
| Cowen & Co. | Derrick Wood | $98 | $69.22 | -37.0% | Jun 9, 2022 |
| Barclays | Raimo Lenschow | $82 | $72.69 | -47.3% | Jun 7, 2022 |
| Morgan Stanley | Keith Weiss | $88 | $73.07 | -43.5% | Jun 6, 2022 |
| Monness | Brian White | $126 | $72.97 | -19.0% | Jun 6, 2022 |
| Jefferies | Brent Thill | $75 | $69.94 | -51.8% | May 23, 2022 |
| BMO Capital | Keith Bachman | $92 | $77.52 | -40.9% | Mar 11, 2022 |
| Bank of America Securities | Bradley Sills | $90 | $77.52 | -42.2% | Mar 11, 2022 |
| Societe Generale | Richard Nguyen | $98 | $77.52 | -37.0% | Mar 11, 2022 |
| Wolfe Research | Alex Zukin | $83 | $77.82 | -46.7% | Mar 11, 2022 |
| Evercore ISI | Kirk Materne | $88 | $77.52 | -43.5% | Mar 11, 2022 |
| Jefferies | Brent Thill | $80 | $75.8 | -48.6% | Mar 9, 2022 |
| Cowen & Co. | Derrick Wood | $100 | $75.8 | -35.7% | Mar 9, 2022 |
| UBS | Karl Keirstead | $75 | $73.04 | -51.8% | Mar 8, 2022 |
| Deutsche Bank | Brad Zelnick | $110 | $73.04 | -29.3% | Mar 8, 2022 |
| DZ BANK AG | Ingo Wermann | $105 | $102.86 | -32.5% | Dec 15, 2021 |
| Citigroup | Tyler Radke | $100 | $100.12 | -35.7% | Dec 13, 2021 |
| Morgan Stanley | Keith Weiss | $87 | $85.22 | -44.1% | Sep 20, 2021 |
| Goldman Sachs | Kash Rangan | $66 | $85.44 | -57.6% | Sep 14, 2021 |
Track every rating change on ORCL the moment it posts. Free to start.
Start free